title: Successful Treatment of Multicentric Reticulohistiocytosis with Adalimumab, Prednisolone and Methotrexate.
authors.affiliation: Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. smotegi@gunma-u.ac.jp.
authors.forename: Sei-Ichiro
authors.initials: S
authors.lastname: Motegi
authors.forename: Yukio
authors.initials: Y
authors.lastname: Yonemoto
authors.forename: Shinya
authors.initials: S
authors.lastname: Yanagisawa
authors.forename: Sayaka
authors.initials: S
authors.lastname: Toki
authors.forename: Akihiko
authors.initials: A
authors.lastname: Uchiyama
authors.forename: Kazuya
authors.initials: K
authors.lastname: Yamada
authors.forename: Osamu
authors.initials: O
authors.lastname: Ishikawa
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D050823:Hand Joints / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000276:immunology; D015616:Histiocytosis, Non-Langerhans-Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use*; D011859:Radiography; D012074:Remission Induction; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D011239:Prednisolone; D000068879:Adalimumab; D008727:Methotrexate